Rasna Therapeutics Stock Market Value

RASP Stock  USD 0  0.00  0.00%   
Rasna Therapeutics' market value is the price at which a share of Rasna Therapeutics trades on a public exchange. It measures the collective expectations of Rasna Therapeutics investors about its performance. Rasna Therapeutics is selling at 0.004 as of the 23rd of December 2024; that is No Change since the beginning of the trading day. The stock's last reported lowest price was 0.004.
With this module, you can estimate the performance of a buy and hold strategy of Rasna Therapeutics and determine expected loss or profit from investing in Rasna Therapeutics over a given investment horizon. Check out Rasna Therapeutics Correlation, Rasna Therapeutics Volatility and Rasna Therapeutics Alpha and Beta module to complement your research on Rasna Therapeutics.
Symbol

Please note, there is a significant difference between Rasna Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Rasna Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rasna Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Rasna Therapeutics 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Rasna Therapeutics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Rasna Therapeutics.
0.00
11/23/2024
No Change 0.00  0.0 
In 31 days
12/23/2024
0.00
If you would invest  0.00  in Rasna Therapeutics on November 23, 2024 and sell it all today you would earn a total of 0.00 from holding Rasna Therapeutics or generate 0.0% return on investment in Rasna Therapeutics over 30 days. Rasna Therapeutics is related to or competes with Watsco, Fastenal, SiteOne Landscape, Ferguson Plc, and WW Grainger. Rasna Therapeutics, Inc., a leukemia-focused biotechnology company, engages in developing therapeutics for the treatment... More

Rasna Therapeutics Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Rasna Therapeutics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Rasna Therapeutics upside and downside potential and time the market with a certain degree of confidence.

Rasna Therapeutics Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Rasna Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Rasna Therapeutics' standard deviation. In reality, there are many statistical measures that can use Rasna Therapeutics historical prices to predict the future Rasna Therapeutics' volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Rasna Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.0000.00
Details
Intrinsic
Valuation
LowRealHigh
0.0000.00
Details
Naive
Forecast
LowNextHigh
000
Details

Rasna Therapeutics Backtested Returns

We have found three technical indicators for Rasna Therapeutics, which you can use to evaluate the volatility of the company. The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Rasna Therapeutics are completely uncorrelated.

Auto-correlation

    
  0.00  

No correlation between past and present

Rasna Therapeutics has no correlation between past and present. Overlapping area represents the amount of predictability between Rasna Therapeutics time series from 23rd of November 2024 to 8th of December 2024 and 8th of December 2024 to 23rd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Rasna Therapeutics price movement. The serial correlation of 0.0 indicates that just 0.0% of current Rasna Therapeutics price fluctuation can be explain by its past prices.
Correlation Coefficient0.0
Spearman Rank Test1.0
Residual Average0.0
Price Variance0.0

Rasna Therapeutics lagged returns against current returns

Autocorrelation, which is Rasna Therapeutics pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Rasna Therapeutics' pink sheet expected returns. We can calculate the autocorrelation of Rasna Therapeutics returns to help us make a trade decision. For example, suppose you find that Rasna Therapeutics has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Rasna Therapeutics regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Rasna Therapeutics pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Rasna Therapeutics pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Rasna Therapeutics pink sheet over time.
   Current vs Lagged Prices   
       Timeline  

Rasna Therapeutics Lagged Returns

When evaluating Rasna Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Rasna Therapeutics pink sheet have on its future price. Rasna Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Rasna Therapeutics autocorrelation shows the relationship between Rasna Therapeutics pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Rasna Therapeutics.
   Regressed Prices   
       Timeline  

Pair Trading with Rasna Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Rasna Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rasna Therapeutics will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Rasna Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Rasna Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Rasna Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Rasna Therapeutics to buy it.
The correlation of Rasna Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Rasna Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Rasna Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Rasna Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Rasna Pink Sheet Analysis

When running Rasna Therapeutics' price analysis, check to measure Rasna Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rasna Therapeutics is operating at the current time. Most of Rasna Therapeutics' value examination focuses on studying past and present price action to predict the probability of Rasna Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rasna Therapeutics' price. Additionally, you may evaluate how the addition of Rasna Therapeutics to your portfolios can decrease your overall portfolio volatility.